WZ4002 [Ligand Id: 9176] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL1229592
  • ALK receptor tyrosine kinase/ALK tyrosine kinase receptor in Human [ChEMBL: CHEMBL4247] [GtoPdb: 1839] [UniProtKB: Q9UM73]
There should be some charts here, you may need to enable JavaScript!
  • cathepsin C/Dipeptidyl peptidase I in Human [ChEMBL: CHEMBL2252] [GtoPdb: 2344] [UniProtKB: P53634]
There should be some charts here, you may need to enable JavaScript!
  • epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533]
There should be some charts here, you may need to enable JavaScript!
  • ABL proto-oncogene 1, non-receptor tyrosine kinase/Tyrosine-protein kinase ABL in Mouse [ChEMBL: CHEMBL3099] [GtoPdb: 1923] [UniProtKB: P00520]
There should be some charts here, you may need to enable JavaScript!
  • Janus kinase 3/Tyrosine-protein kinase JAK3 in Human [ChEMBL: CHEMBL2148] [GtoPdb: 2049] [UniProtKB: P52333]
There should be some charts here, you may need to enable JavaScript!
  • erb-b2 receptor tyrosine kinase 4 in Human [GtoPdb: 1799] [UniProtKB: Q15303]
There should be some charts here, you may need to enable JavaScript!
  • BLK proto-oncogene, Src family tyrosine kinase in Human [GtoPdb: 1940] [UniProtKB: P51451]
There should be some charts here, you may need to enable JavaScript!
  • Bruton tyrosine kinase in Human [GtoPdb: 1948] [UniProtKB: Q06187]
There should be some charts here, you may need to enable JavaScript!
  • IL2 inducible T cell kinase in Human [GtoPdb: 2046] [UniProtKB: Q08881]
There should be some charts here, you may need to enable JavaScript!
  • NUAK family kinase 1 in Human [GtoPdb: 2129] [UniProtKB: O60285]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
ALK receptor tyrosine kinase/ALK tyrosine kinase receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4247] [GtoPdb: 1839] [UniProtKB: Q9UM73]
ChEMBL Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay B 6 pIC50 990 nM IC50 Eur J Med Chem (2017) 136: 497-510 [PMID:28528303]
cathepsin C/Dipeptidyl peptidase I in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2252] [GtoPdb: 2344] [UniProtKB: P53634]
ChEMBL Inhibition of CatL-activated recombinant human C-terminal His10-tagged cathepsin C (25 to 463 residues) expressed in mouse myeloma cells using Gly-Phe-AFC as substrate preincubated for 3 hrs followed by substrate addition and measured after 60 mins B 5.68 pIC50 2100 nM IC50 J Med Chem (2019) 62: 5901-5919 [PMID:31145622]
ChEMBL Inhibition of cathepsin C (unknown origin) B 5.68 pIC50 2100 nM IC50 J Med Chem (2019) 62: 5901-5919 [PMID:31145622]
epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533]
ChEMBL Binding affinity to recombinant EGFR L858R/T90M mutant B 6.89 pKd 130 nM Kd J Med Chem (2012) 55: 6243-6262 [PMID:22621397]
ChEMBL Binding affinity to EGFR B 7.34 pKd 46 nM Kd J Med Chem (2012) 55: 2711-2723 [PMID:22339342]
GtoPdb - - 7.34 pKd 46 nM Kd Nature (2009) 462: 1070-4 [PMID:20033049]
ChEMBL Binding affinity to EGFR L858R mutant B 7.54 pKd 29 nM Kd J Med Chem (2012) 55: 2711-2723 [PMID:22339342]
ChEMBL Binding affinity to partial length human EGFR L858R/T790M double mutant expressed in mammalian system by KINOMEscan assay B 9.52 pKd 0.3 nM Kd J Med Chem (2016) 59: 6580-6594 [PMID:26882288]
ChEMBL Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay B 4.74 pIC50 18210 nM IC50 Bioorg Med Chem Lett (2017) 27: 4832-4837 [PMID:28974338]
ChEMBL Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay B 5.07 pIC50 8600 nM IC50 Bioorg Med Chem Lett (2017) 27: 4832-4837 [PMID:28974338]
ChEMBL Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method B 5.69 pIC50 2050 nM IC50 J Med Chem (2017) 60: 4636-4656 [PMID:28482151]
ChEMBL Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay B 5.93 pIC50 1180 nM IC50 J Med Chem (2013) 56: 7025-7048 [PMID:23930994]
ChEMBL Inhibition of wild-type EGFR phosphorylation in human A431 cells preincubated for 1 hr followed by EGF stimulation measured after 45 mins by ELISA B 6.15 pIC50 710 nM IC50 Bioorg Med Chem Lett (2018) 28: 1257-1261 [PMID:29534926]
ChEMBL Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay B 6.92 pIC50 120 nM IC50 Eur J Med Chem (2017) 136: 497-510 [PMID:28528303]
ChEMBL Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay B 6.96 pIC50 110 nM IC50 Bioorg Med Chem Lett (2017) 27: 4832-4837 [PMID:28974338]
ChEMBL Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay B 7.1 pIC50 79 nM IC50 Eur J Med Chem (2015) 104: 115-126 [PMID:26451770]
ChEMBL Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA B 7.34 pIC50 46 nM IC50 Bioorg Med Chem Lett (2018) 28: 1257-1261 [PMID:29534926]
ChEMBL Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA B 7.51 pIC50 31.1 nM IC50 Bioorg Med Chem (2016) 24: 2673-2680 [PMID:27131639]
ChEMBL Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay B 7.51 pIC50 31 nM IC50 Eur J Med Chem (2015) 104: 115-126 [PMID:26451770]
ChEMBL Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay B 7.64 pIC50 23 nM IC50 J Med Chem (2013) 56: 7025-7048 [PMID:23930994]
ChEMBL Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay B 7.74 pIC50 18 nM IC50 Bioorg Med Chem Lett (2018) 28: 1257-1261 [PMID:29534926]
ChEMBL Inhibition of wild type N-terminal His6-tagged human EGFR kinase domain (702 to 1016 residues) expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay B 7.8 pIC50 16 nM IC50 Bioorg Med Chem (2015) 23: 2767-2780 [PMID:25975640]
ChEMBL Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay B 8 pIC50 10 nM IC50 J Med Chem (2015) 58: 6844-6863 [PMID:26275028]
ChEMBL Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA B 8.01 pIC50 9.7 nM IC50 Bioorg Med Chem (2016) 24: 2673-2680 [PMID:27131639]
ChEMBL Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay B 8.09 pIC50 8.13 nM IC50 Medchemcomm (2012) 3: 1155-1159
ChEMBL Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay B 8.19 pIC50 6.47 nM IC50 Medchemcomm (2012) 3: 1155-1159
ChEMBL Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA B 8.19 pIC50 6.4 nM IC50 Medchemcomm (2015) 6: 1693-1697
ChEMBL Inhibition of EGFR after 1.5 hr by FRET assay B 8.21 pIC50 6.18 nM IC50 J Med Chem (2012) 55: 2711-2723 [PMID:22339342]
ChEMBL Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay B 8.21 pIC50 6.13 nM IC50 J Med Chem (2012) 55: 2711-2723 [PMID:22339342]
ChEMBL Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay B 8.27 pIC50 5.4 nM IC50 Eur J Med Chem (2013) 66: 82-90 [PMID:23792318]
ChEMBL Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay B 8.27 pIC50 5.4 nM IC50 J Med Chem (2013) 56: 4738-4748 [PMID:23668441]
ChEMBL Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay B 8.27 pIC50 5.37 nM IC50 J Med Chem (2012) 55: 2711-2723 [PMID:22339342]
ChEMBL Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay B 8.3 pIC50 5 nM IC50 Eur J Med Chem (2017) 136: 497-510 [PMID:28528303]
ChEMBL Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay B 8.32 pIC50 4.8 nM IC50 Eur J Med Chem (2014) 77: 75-83 [PMID:24607591]
ChEMBL Inhibition of N-terminal GST-tagged human recombinant EGFR L858R mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay B 8.33 pIC50 4.64 nM IC50 Eur J Med Chem (2021) 211: 113022-113022 [PMID:33239261]
ChEMBL Inhibition of N-terminal GST-tagged human recombinant EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay B 8.34 pIC50 4.59 nM IC50 Eur J Med Chem (2021) 211: 113022-113022 [PMID:33239261]
ChEMBL Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay B 8.36 pIC50 4.4 nM IC50 Eur J Med Chem (2014) 77: 75-83 [PMID:24607591]
ChEMBL Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay B 8.37 pIC50 4.25 nM IC50 Medchemcomm (2012) 3: 1155-1159
ChEMBL Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay B 8.4 pIC50 4 nM IC50 Eur J Med Chem (2017) 136: 497-510 [PMID:28528303]
ChEMBL Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay B 8.42 pIC50 3.82 nM IC50 J Med Chem (2013) 56: 7821-7837 [PMID:24053674]
ChEMBL Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay B 8.42 pIC50 3.77 nM IC50 J Med Chem (2012) 55: 2711-2723 [PMID:22339342]
ChEMBL Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay B 8.49 pIC50 3.2 nM IC50 Eur J Med Chem (2013) 66: 82-90 [PMID:23792318]
ChEMBL Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay B 8.49 pIC50 3.2 nM IC50 J Med Chem (2013) 56: 4738-4748 [PMID:23668441]
ChEMBL Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay B 8.52 pIC50 3 nM IC50 Bioorg Med Chem Lett (2018) 28: 1257-1261 [PMID:29534926]
ChEMBL Inhibition of N-terminal GST-tagged human recombinant EGFR L861Q mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay B 8.54 pIC50 2.86 nM IC50 Eur J Med Chem (2021) 211: 113022-113022 [PMID:33239261]
ChEMBL Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay B 8.61 pIC50 2.47 nM IC50 Medchemcomm (2012) 3: 1155-1159
ChEMBL Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay B 8.67 pIC50 2.16 nM IC50 J Med Chem (2013) 56: 7821-7837 [PMID:24053674]
ChEMBL Inhibition of N-terminal GST-tagged human recombinant EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay B 8.7 pIC50 1.98 nM IC50 Eur J Med Chem (2021) 211: 113022-113022 [PMID:33239261]
ChEMBL Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay B 8.73 pIC50 1.88 nM IC50 J Med Chem (2012) 55: 2711-2723 [PMID:22339342]
ChEMBL Inhibition of EGFR kinase L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay B 8.74 pIC50 1.82 nM IC50 Medchemcomm (2012) 3: 1155-1159
ChEMBL Inhibition of EGFR (unknown origin) using biotin-labelled peptide as substrate preincubated for 2 hrs followed by substrate addition and measured after 30 mins by HTRF FRET assay B 8.77 pIC50 1.7 nM IC50 J Med Chem (2019) 62: 5901-5919 [PMID:31145622]
ChEMBL Inhibition of EGFR L858R mutant (unknown origin) B 8.96 pIC50 1.1 nM IC50 J Med Chem (2017) 60: 4636-4656 [PMID:28482151]
ChEMBL Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay B 9 pIC50 <1 nM IC50 J Med Chem (2017) 60: 7725-7744 [PMID:28853575]
ChEMBL Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay B 9 pIC50 <1 nM IC50 J Med Chem (2015) 58: 6844-6863 [PMID:26275028]
ChEMBL Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay B 9 pIC50 <1 nM IC50 J Med Chem (2017) 60: 5613-5637 [PMID:28603991]
ChEMBL Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay B 9 pIC50 <1 nM IC50 J Med Chem (2017) 60: 5613-5637 [PMID:28603991]
ChEMBL Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay B 9 pIC50 <1 nM IC50 J Med Chem (2017) 60: 7725-7744 [PMID:28853575]
ChEMBL Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay B 9 pIC50 <1 nM IC50 J Med Chem (2015) 58: 6844-6863 [PMID:26275028]
ChEMBL Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay B 9.1 pIC50 0.8 nM IC50 Bioorg Med Chem (2018) 26: 1740-1750 [PMID:29523467]
ChEMBL Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay B 9.1 pIC50 0.8 nM IC50 Eur J Med Chem (2013) 66: 82-90 [PMID:23792318]
ChEMBL Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay B 9.1 pIC50 0.8 nM IC50 J Med Chem (2013) 56: 4738-4748 [PMID:23668441]
ChEMBL Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay B 9.15 pIC50 0.7 nM IC50 Eur J Med Chem (2014) 77: 75-83 [PMID:24607591]
ChEMBL Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay B 9.18 pIC50 0.66 nM IC50 J Med Chem (2013) 56: 7821-7837 [PMID:24053674]
ChEMBL Inhibition of EGFR L858R/T790M double mutant (unknown origin) B 9.3 pIC50 <0.5 nM IC50 J Med Chem (2017) 60: 4636-4656 [PMID:28482151]
ChEMBL Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay B 9.38 pIC50 0.42 nM IC50 Bioorg Med Chem (2015) 23: 2767-2780 [PMID:25975640]
ChEMBL Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay B 9.72 pIC50 0.19 nM IC50 Bioorg Med Chem (2015) 23: 2767-2780 [PMID:25975640]
ChEMBL Inhibition of recombinant human N-terminal GST tagged EGFR L858R/T790M double mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay B 10.4 pIC50 0.04 nM IC50 Bioorg Med Chem (2018) 26: 1740-1750 [PMID:29523467]
ChEMBL Inhibition of wild type EGFR (unknown origin) transfected in mouse BAF3 cells assessed as reduction in cell viability after 72 hrs by MTS assay B 6 pEC50 989 nM EC50 Eur J Med Chem (2017) 136: 497-510 [PMID:28528303]
ChEMBL Inhibition of EGFR exon19 deletion mutant (unknown origin) transfected in mouse BAF3 cells assessed as reduction in cell viability after 72 hrs by MTS assay B 7.17 pEC50 68 nM EC50 Eur J Med Chem (2017) 136: 497-510 [PMID:28528303]
ChEMBL Inhibition of EGFR T790M/L858R double mutant (unknown origin) transfected in mouse BAF3 cells assessed as reduction in cell viability after 72 hrs by MTS assay B 7.51 pEC50 31 nM EC50 Eur J Med Chem (2017) 136: 497-510 [PMID:28528303]
ChEMBL Inhibition of EGFR T790M exon19 deletion double mutant (unknown origin) transfected in mouse BAF3 cells assessed as reduction in cell viability after 72 hrs by MTS assay B 7.57 pEC50 27 nM EC50 Eur J Med Chem (2017) 136: 497-510 [PMID:28528303]
ChEMBL Inhibition of EGFR L858R mutant (unknown origin) transfected in mouse BAF3 cells assessed as reduction in cell viability after 72 hrs by MTS assay B 7.59 pEC50 26 nM EC50 Eur J Med Chem (2017) 136: 497-510 [PMID:28528303]
ABL proto-oncogene 1, non-receptor tyrosine kinase/Tyrosine-protein kinase ABL in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3099] [GtoPdb: 1923] [UniProtKB: P00520]
ChEMBL Inhibition of ABL T315I mutant in mouse BAF3 cells assessed as reduction in cell viability after 72 hrs by MTT assay B 4.79 pIC50 16280 nM IC50 Bioorg Med Chem Lett (2017) 27: 4832-4837 [PMID:28974338]
ChEMBL Inhibition of ABL in mouse BAF3 cells assessed as reduction in cell viability after 72 hrs by MTT assay B 5.01 pIC50 9690 nM IC50 Bioorg Med Chem Lett (2017) 27: 4832-4837 [PMID:28974338]
Janus kinase 3/Tyrosine-protein kinase JAK3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2148] [GtoPdb: 2049] [UniProtKB: P52333]
ChEMBL Binding affinity to JAK3 (unknown origin) B 6.82 pKd 150 nM Kd J Med Chem (2015) 58: 6589-6606 [PMID:26258521]
erb-b2 receptor tyrosine kinase 4 in Human [GtoPdb: 1799] [UniProtKB: Q15303]
GtoPdb - - 7.55 pKd 28 nM Kd Nature (2009) 462: 1070-4 [PMID:20033049]
BLK proto-oncogene, Src family tyrosine kinase in Human [GtoPdb: 1940] [UniProtKB: P51451]
GtoPdb - - 6.7 pKd 200 nM Kd Nature (2009) 462: 1070-4 [PMID:20033049]
Bruton tyrosine kinase in Human [GtoPdb: 1948] [UniProtKB: Q06187]
GtoPdb - - 7.37 pKd 43 nM Kd Nature (2009) 462: 1070-4 [PMID:20033049]
IL2 inducible T cell kinase in Human [GtoPdb: 2046] [UniProtKB: Q08881]
GtoPdb - - 7.37 pKd 43 nM Kd Nature (2009) 462: 1070-4 [PMID:20033049]
NUAK family kinase 1 in Human [GtoPdb: 2129] [UniProtKB: O60285]
GtoPdb - - 7.04 pKd 91 nM Kd Nature (2009) 462: 1070-4 [PMID:20033049]

ChEMBL data shown on this page come from version 32:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]